Medical Director, Oncology Clinical Development (Solid Tumors)

Job overview

The Medical Director, Oncology Clinical Development (Solid Tumors) role is onsite in Waltham, MA. Compensation is not specified. AbbVie’s mission is to discover and deliver medicines and solutions for serious health issues, including oncology. With appropriate supervision, this physician oversees clinical trial planning, execution, and interpretation for a development program. The role contributes medical and scientific expertise to study design, safety and efficacy review, regulatory and program documents, and cross-functional clinical strategy.

What you'll do

• With appropriate supervision, manage study protocol design and implementation and educate investigators and study staff
• oversee clinical study integrity, enrollment, timelines, and accumulating safety and efficacy data
• assess and report serious adverse events for assigned protocols
• contribute to scientific content for protocols, Investigator Brochures, Clinical Study Reports, regulatory submissions, and responses
• participate in clinical strategy and opinion-leader interactions as applicable
• maintain knowledge of medical literature and regulatory requirements
• ensure adherence to Good Clinical Practices, pharmacovigilance standards, and quality procedures.

What we're looking for

Skills & competencies

medical director

oncology

clinical development

solid tumors

waltham ma

abbvie

clinical trials

study protocols

drug development

good clinical practices

pharmacovigilance

Work arrangement

• Weekend coverage required

Benefits & perks

• Eligible employees may receive paid time off, medical, dental, and vision insurance, 401(k), and participation in long-term incentive programs.

Why this role

Clinical development leadership focused on solid tumors, with responsibilities spanning trial oversight, scientific documentation, and regulatory compliance.

About the employer

AbbVie is hiring for this role. Industry: Research and Development in Biotechnology (except Nanobiotechnology). Sector: 54.